CD8A and lymphopenia: As a result, both CD4+ and CD8+ T cell counts were drastically reduced upon RMD administration (Fig 6b and 6c, respectively), but similar to the overall lymphopenia, they rebounded to pretreatment levels within one week (Fig 6b and 6c).